Literature DB >> 17463316

Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials.

Philip M W Bath, Laura J Gray, Timothy Collier, Stuart Pocock, James Carpenter.   

Abstract

BACKGROUND AND
PURPOSE: Most large acute stroke trials have been neutral. Functional outcome is usually analyzed using a yes or no answer, eg, death or dependency versus independence. We assessed which statistical approaches are most efficient in analyzing outcomes from stroke trials.
METHODS: Individual patient data from acute, rehabilitation and stroke unit trials studying the effects of interventions which alter functional outcome were assessed. Outcomes included modified Rankin Scale, Barthel Index, and "3 questions". Data were analyzed using a variety of approaches which compare 2 treatment groups. The results for each statistical test for each trial were then compared.
RESULTS: Data from 55 datasets were obtained (47 trials, 54,173 patients). The test results differed substantially so that approaches which use the ordered nature of functional outcome data (ordinal logistic regression, t test, robust ranks test, bootstrapping the difference in mean rank) were more efficient statistically than those which collapse the data into 2 groups (chi(2); ANOVA, P<0.001). The findings were consistent across different types and sizes of trial and for the different measures of functional outcome.
CONCLUSIONS: When analyzing functional outcome from stroke trials, statistical tests which use the original ordered data are more efficient and more likely to yield reliable results. Suitable approaches included ordinal logistic regression, t test, and robust ranks test.

Entities:  

Mesh:

Year:  2007        PMID: 17463316     DOI: 10.1161/STROKEAHA.106.474080

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  78 in total

Review 1.  Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?

Authors:  H Bart van der Worp; Malcolm R Macleod; Rainer Kollmar
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

2.  Impact of GOS misclassification on ordinal outcome analysis of traumatic brain injury clinical trials.

Authors:  Juan Lu; Anthony Marmarou; Kate L Lapane
Journal:  J Neurotrauma       Date:  2011-09-21       Impact factor: 5.269

Review 3.  Clinical trial design in the neurocritical care unit.

Authors:  C E Hall; M Mirski; Y Y Palesch; M N Diringer; A I Qureshi; C S Robertson; R Geocadin; C A C Wijman; P D Le Roux; Jose I Suarez
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

4.  C-reactive protein is associated with disability independently of vascular events: the Northern Manhattan Study.

Authors:  Mandip S Dhamoon; Ying-Kuen Cheung; Yeseon P Moon; Clinton B Wright; Joshua Z Willey; Ralph Sacco; Mitchell Sv Elkind
Journal:  Age Ageing       Date:  2017-01-15       Impact factor: 10.668

5.  Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial.

Authors:  Stacia M Desantis; Christos Lazaridis; Yuko Palesch; Viswanathan Ramakrishnan
Journal:  Int J Stroke       Date:  2013-06-27       Impact factor: 5.266

Review 6.  How to Measure Recovery? Revisiting Concepts and Methods for Stroke Studies.

Authors:  Marc Hommel; Olivier Detante; Isabelle Favre; Emmanuel Touzé; Assia Jaillard
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

Review 7.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

8.  Analysis of the compliance and the related influence factors in the follow-up process of surveillance for Creutzfeldt-Jakob disease in China.

Authors:  Xiao-Mei Zhang; Kang Xiao; Wei Zhou; Cao Chen; Yan Lv; Li-Na Chen; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2014       Impact factor: 3.931

9.  Functional Trajectories, Cognition, and Subclinical Cerebrovascular Disease.

Authors:  Mandip S Dhamoon; Ying-Kuen Cheung; Jose Gutierrez; Yeseon P Moon; Ralph L Sacco; Mitchell S V Elkind; Clinton B Wright
Journal:  Stroke       Date:  2018-01-26       Impact factor: 7.914

10.  Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke.

Authors:  E M Arsava; R Rahman; J Rosand; J Lu; E E Smith; N S Rost; A B Singhal; M H Lev; K L Furie; W J Koroshetz; A G Sorensen; H Ay
Journal:  Neurology       Date:  2009-04-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.